GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma

Hiroyuki Muranushi, Takero Shindo, Masakatsu Hishizawa, Masahito Tokunaga, Atsushi Wake, Nobuaki Nakano, Tetsuya Eto, Michihiro Hidaka, Ilseung Choi, Toshihiro Miyamoto, Naoyuki Uchida, Yukiyoshi Moriuchi, Yasuhiko Miyazaki, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, The ATL Working Group of the Japanese Society for Hematopoietic Cell Transplantation, Makoto Yoshimitsu, Takashi Ishida, Atae Utsunomiya, Koji Kato, Junji Suzumiya, Tomomi Tobai, Koichi Nakase, Yuichiro Nawa, Masakatsu Hishizawa, Takuya Fukushima, Atsushi Wake, Ilseung Choi, Yoshitaka Asakura, Nobuaki Nakano, Hiroshi Fujiwara, Shinichiro Machida, Yasushi Sawayama, Yoshitaka Inoue, Kazunori Imada, Isao Yoshida, Shigeo Fuji, Takahiro Fukuda, Takero Shindo, Masahito Tokunaga, Hiroyuki Muranushi, Satoko Morishima, Shohei Tomori, Tomoki Iemura, Takuya Shimizu, Mari Morita‐Fujita, Koji Kato